These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23719903)

  • 1. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application.
    Antkiewicz-Michaluk L; Wąsik A; Michaluk J
    Neurotox Res; 2014 Jan; 25(1):1-12. PubMed ID: 23719903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.
    Antkiewicz-Michaluk L; Filip M; Michaluk J; Romańska I; Przegaliński E; Vetulani J
    J Neural Transm (Vienna); 2007 Mar; 114(3):307-17. PubMed ID: 16897599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study.
    Wąsik A; Romańska I; Antkiewicz-Michaluk L
    Pharmacol Rep; 2010; 62(6):983-97. PubMed ID: 21273655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity.
    Antkiewicz-Michaluk L; Lazarewicz JW; Patsenka A; Kajta M; Zieminska E; Salinska E; Wasik A; Golembiowska K; Vetulani J
    J Neurochem; 2006 May; 97(3):846-56. PubMed ID: 16515537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.
    Pietraszek M; Michaluk J; Romańska I; Wasik A; Gołembiowska K; Antkiewicz-Michaluk L
    Neurotox Res; 2009 Nov; 16(4):390-407. PubMed ID: 19649683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an endogenous compound 1-methyl-1,2,3,4,-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures.
    Wasik A; Romańska I; Antkiewicz-Michaluk L
    J Physiol Pharmacol; 2007 Jun; 58(2):235-52. PubMed ID: 17622694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
    Wąsik A; Romańska I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-Like Effect of the Endogenous Neuroprotective Amine, 1MeTIQ in Clonidine-Induced Depression: Behavioral and Neurochemical Studies in Rats.
    Antkiewicz-Michaluk L; Romańska I; Wąsik A; Michaluk J
    Neurotox Res; 2017 Jul; 32(1):94-106. PubMed ID: 28367606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like activity of the endogenous amine, 1-methyl-1,2,3,4-tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: a comparison with the classical antidepressant, imipramine.
    Wąsik A; Możdżeń E; Romańska I; Michaluk J; Antkiewicz-Michaluk L
    Eur J Pharmacol; 2013 Jan; 700(1-3):110-7. PubMed ID: 23246532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
    Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
    Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release.
    Antkiewicz-Michaluk L; Wąsik A; Romańska I; Bojarski A; Michaluk J
    Neurotox Res; 2011 Aug; 20(2):134-49. PubMed ID: 21069490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous Neuroprotectant and MAO inhibitor with antidepressant-like properties in the rat.
    Wąsik A; Możdżeń E; Michaluk J; Romańska I; Antkiewicz-Michaluk L
    Neurotox Res; 2014 May; 25(4):323-34. PubMed ID: 24065621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.
    Kotake Y; Taguchi R; Okuda K; Sekiya Y; Tasaki Y; Hirobe M; Ohta S
    Brain Res; 2005 Feb; 1033(2):143-50. PubMed ID: 15694918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Protective Effect of Repeated 1MeTIQ Administration on the Lactacystin-Induced Impairment of Dopamine Release and Decline in TH Level in the Rat Brain.
    Wąsik A; Romańska I; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
    Neurotox Res; 2018 Oct; 34(3):706-716. PubMed ID: 30129004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative behavioral and neurochemical studies of R- and S-1-methyl-1,2,3,4-tetrahydroisoquinoline stereoisomers in the rat.
    Wąsik A; Romańska I; Michaluk J; Antkiewicz-Michaluk L
    Pharmacol Rep; 2012; 64(4):857-69. PubMed ID: 23087137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
    Wąsik A; Romańska I; Michaluk J; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
    Neurotox Res; 2016 Apr; 29(3):351-63. PubMed ID: 26303030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment.
    Wąsik A; Białoń M; Żarnowska M; Antkiewicz-Michaluk L
    Pharmacol Biochem Behav; 2019 Jun; 181():17-27. PubMed ID: 30965047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Neurotox Res; 2014 Jul; 26(1):85-98. PubMed ID: 24407488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Methyl-1,2,3,4-tetrahydroisoquinoline and established uncompetitive NMDA receptor antagonists induce tolerance to excitotoxicity.
    Kuszczyk M; Słomka M; Antkiewicz-Michaluk L; Salińska E; Łazarewicz JW
    Pharmacol Rep; 2010; 62(6):1041-50. PubMed ID: 21273661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.